Clinical Trials in Toyohashi, Aichi

Find clinical trials in Toyohashi, Aichi. Discover local research opportunities and treatment options in your area.

9 Active Trials Found in Toyohashi

Showing 9 trials on this page

Page 1 of 1

A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments

NCT ID: NCT05020236

The MagnetisMM-5 clinical trial is studying a new treatment option for people with relapsed or refractory multiple myeloma, a type of blood cancer. Researchers want to see if a medication called el...

Recruiting

Phase: PHASE3 Conditions: Multiple Myeloma

MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)

NCT ID: NCT06152575

The MagnetisMM-32 clinical trial is studying a new medicine called elranatamab for people with multiple myeloma (MM), a type of blood cancer that has returned after previous treatments. The trial a...

Recruiting

Phase: PHASE3 Conditions: Multiple Myeloma

A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma

NCT ID: NCT06742996

This clinical trial is studying a new combination treatment for adults with a type of cancer called mantle cell lymphoma (MCL) that has come back or has not responded to previous treatments. The re...

Recruiting

Phase: PHASE3 Conditions: Mantle Cell Lymphoma, B Cell Lymphoma

Non-antithrombotic Versus. Single Antiplatelet Therapy Following Left Atrial Appendage Closure

NCT ID: NCT07125417

This clinical trial is studying the best way to prevent blood clots after a procedure called left atrial appendage closure (LAAC), which is done to lower stroke risk in people with a common heart r...

Recruiting

Phase: PHASE4 Conditions: Aspirin, Left Atrial Appendage Closure +3 more

Specified Drug-use Surveillance of Fabhalta Capsules

NCT ID: NCT06606314

This clinical trial is studying Fabhalta capsules, a treatment for a rare blood condition called Paroxysmal Nocturnal Hemoglobinuria (PNH). The trial is designed to gather information about how wel...

Recruiting

Conditions: Paroxysmal Nocturnal Hemoglobinuria

A Study to Assess the Safety, Tolerability, Efficacy, and Drug Levels of BMS-986369 (Golcadomide) in Participants With Relapsed or Refractory T-cell Lymphomas in Japan (GOLSEEK-3)

NCT ID: NCT06035497

This clinical trial is studying a new drug called BMS-986369 to see how safe it is, how well it works, and how much of the drug gets into the body in people with certain types of T-cell lymphomas t...

Recruiting

Phase: PHASE1 Conditions: Relapsed or Refractory T-cell Lymphomas

An Observational Study to Assess Change in Disease Activity and Adverse Events in Adolescent and Adult Participants With Moderate to Severe Active Crohn's Disease (CD) in Japan

NCT ID: NCT06023030

This clinical trial is studying the effects of a medication called upadacitinib on people with moderate to severe Crohn's disease, a long-term condition that causes inflammation in the digestive tr...

Recruiting

Conditions: Crohn's Disease

Amplatzer Amulet LAAO vs. NOAC

NCT ID: NCT04226547

This clinical trial is studying two different treatments for patients with a heart condition called atrial fibrillation (AF), which increases the risk of stroke. One treatment being tested is a dev...

Recruiting

Phase: NA Conditions: Stroke, Atrial Fibrillation +1 more

Long-term Extension Study of Zanubrutinib (BGB-3111) Regimens in Participants With B-cell Malignancies

NCT ID: NCT04170283

This is a long-term extension study to look at the safety and some outcomes of zanubrutinib (a cancer drug that targets BTK) in people who have B-cell cancers and who took part in a BeiGene parent ...

Enrolling by invitation

Phase: PHASE3 Conditions: B-cell Malignancies